Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Choi

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Medrxiv : the Preprint Server for Health Sciences|January 27, 2021
The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human seraRaveen Rathnasinghe, Sonia Jangra, Anastasija Cupic, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
Spatiotemporally organized immunomodulatory response to SARS-CoV-2 virus in primary human broncho-alveolar epitheliaDiana Cadena Castaneda, Sonia Jangra, Marina Yurieva, et al.
Vaccine|November 24, 2021
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in miceKai Wu, Angela Choi, Matthew Koch, et al.
Biorxiv : the Preprint Server for Biology|April 21, 2021
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in miceKai Wu, Angela Choi, Matthew Koch, et al.
Biorxiv : the Preprint Server for Biology|October 14, 2022
Development of SARS-CoV-2 mRNA vaccines encoding spike N-terminal and receptor binding domainsGuillaume B E Stewart-Jones, Sayda M Elbashir, Kai Wu, et al.
Science Translational Medicine|September 13, 2023
Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2Guillaume B E Stewart-Jones, Sayda M Elbashir, Kai Wu, et al.
Nature Communications|July 7, 2022
Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune seraRaveen Rathnasinghe, Sonia Jangra, Chengjin Ye, et al.
Cell Reports|August 21, 2022
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and miceAlexandra C Walls, Laura A VanBlargan, Kai Wu, et al.
Science Translational Medicine|December 18, 2024
An influenza mRNA vaccine protects ferrets from lethal infection with highly pathogenic avian influenza A(H5N1) virusMasato Hatta, Yasuko Hatta, Angela Choi, et al.
Nature|July 25, 2020
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposingLaura Riva, Shuofeng Yuan, Xin Yin, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Medrxiv : the Preprint Server for Health Sciences|January 27, 2021
The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human seraRaveen Rathnasinghe, Sonia Jangra, Anastasija Cupic, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
Spatiotemporally organized immunomodulatory response to SARS-CoV-2 virus in primary human broncho-alveolar epitheliaDiana Cadena Castaneda, Sonia Jangra, Marina Yurieva, et al.
Vaccine|November 24, 2021
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in miceKai Wu, Angela Choi, Matthew Koch, et al.
Biorxiv : the Preprint Server for Biology|April 21, 2021
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in miceKai Wu, Angela Choi, Matthew Koch, et al.
Biorxiv : the Preprint Server for Biology|October 14, 2022
Development of SARS-CoV-2 mRNA vaccines encoding spike N-terminal and receptor binding domainsGuillaume B E Stewart-Jones, Sayda M Elbashir, Kai Wu, et al.
Science Translational Medicine|September 13, 2023
Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2Guillaume B E Stewart-Jones, Sayda M Elbashir, Kai Wu, et al.
Nature Communications|July 7, 2022
Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune seraRaveen Rathnasinghe, Sonia Jangra, Chengjin Ye, et al.
Cell Reports|August 21, 2022
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and miceAlexandra C Walls, Laura A VanBlargan, Kai Wu, et al.
Science Translational Medicine|December 18, 2024
An influenza mRNA vaccine protects ferrets from lethal infection with highly pathogenic avian influenza A(H5N1) virusMasato Hatta, Yasuko Hatta, Angela Choi, et al.
Nature|July 25, 2020
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposingLaura Riva, Shuofeng Yuan, Xin Yin, et al.
Pageof 5